Literature DB >> 10082966

Pteridines as inhibitors of xanthine oxidase: structural requirements.

K Oettl1, G Reibnegger.   

Abstract

Different pteridine derivatives were investigated for their inhibitory action on xanthine oxidase. From 27 investigated compounds, 13 showed concentration-dependent inhibition of the enzyme. Concentrations necessary for 50% inhibition ranged from <0.1 up to >100 microM. Different types of inhibition were found concerning xanthine and pterin as substrates: competitive, noncompetitive and mixed type. Out of 18 aromatic compounds tested, 12 were inhibitors. Only one out of nine reduced derivatives served as inhibitor. A simple regression model was used to specify the structural requirements for a pteridine to be an inhibitor. The most characteristic features of an inhibitor are aromaticity and no substitution at position 7 of the pteridine ring.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082966     DOI: 10.1016/s0167-4838(99)00023-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli.

Authors:  Hyun Bong Park; Zheng Wei; Joonseok Oh; Hao Xu; Chung Sub Kim; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Richard A Flavell; Jason M Crawford
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

2.  Neopterin levels in patients with cerebrovascular disease.

Authors:  Hizir Ulvi; Habib Emre; Recep Demir; Recep Aygul; Asuman Varoğlu; Fatih Kara
Journal:  Eurasian J Med       Date:  2008-08

3.  Serum neopterin levels in patients with breast cancer.

Authors:  Yesim Yildirim; Nazan Gunel; Ugur Coskun; Hatice Pasaoglu; Sabahattin Aslan; Abdullah Cetin
Journal:  Med Oncol       Date:  2008-03-05       Impact factor: 3.064

Review 4.  The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.

Authors:  Ning Liu; Hu Xu; Qianqian Sun; Xiaojuan Yu; Wentong Chen; Hongquan Wei; Jie Jiang; Youzhi Xu; Wenjie Lu
Journal:  Oxid Med Cell Longev       Date:  2021-03-26       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.